Supporting the

Neuroendocrine Cancer Community

NHS Genomics Strategy

NHS Genomics Strategy

NHS Genomics Strategy launched today at #NHSGenomics2022 by @AmandaPritchard It sets out our ambitions over the next 5-10 years to harness the potential of genomics to transform patient care. https://www.england.nhs.uk/genomics/genomics-strategy/
NHS Genomics Strategy Survey

NHS Genomics Strategy Survey

Genetics is the study of genes and their roles in inheritance – in other words, the way that certain traits or conditions are passed down from one generation to the next. In healthcare, genetics has typically focused on variations in a single gene when determining the...
NHS Cancer Quality of Life Survey Launch

NHS Cancer Quality of Life Survey Launch

Monday 25th October saw the launch of the NHS Cancer Quality of Life Survey data dashboard. The survey is for people in England who have been diagnosed with cancer. From 2020, people who have had a breast, prostate or colorectal (bowel) cancer diagnosis are being...
100,000 Genomes Project

100,000 Genomes Project

Genomics : PART ONE : 100,000 Genomes Project – and beyond! In late 2012, the then Prime Minister, David Cameron, announced the 100,000 Genomes Project.  Its four main aims were;  to enable new scientific discovery and medical insights to bring benefit to...
NICE approves Avelumab

NICE approves Avelumab

21st APRIL NICE APPROVES AVELUMAB Neuroendocrine Cancer UK is delighted to share with you NICE’s approval of Avelumab as a first line therapy option in metastatic MCC.  Avelumab is now recommended as an option for treating metastatic Merkel cell carcinoma in adults...